Godrej Agrovet Limited (GAVL) has announced its financial results for the fourth quarter and full year ended March 31, 2025.

During Q4 FY25, GAVL’s consolidated revenues from operations remained flat at Rs. 2,134 crore in Q4 FY25 as compared to Rs. 2,134 crore in Q4 FY24. The company reported consolidated EBITDA, excluding non-recurring & exceptional items, of Rs. 160 crore in Q4 FY25 as compared to Rs. 164 crore in Q4 FY24. GAVL reported Profit before tax, excluding non-recurring & exceptional items, of Rs.74 crore in Q4 FY25 as compared to Rs. 83 crore in Q4 FY24.

For the Financial Year 2024-25, GAVL’s consolidated revenue from operations was Rs. 9,383 crore as compared to Rs. 9,561 crore in FY24. The company reported consolidated EBITDA, excluding non-recurring & exceptional items, of Rs. 845 crore in FY25 as compared to Rs. 757 crore in FY24.GAVL reported Profit before tax, excluding non-recurring & exceptional items, of Rs. 485 crore in FY25 as compared to Rs. 434 crore in FY24.

Commenting on the performance, B. S. Yadav, Managing Director, Godrej Agrovet Limited, said: In the financial year 2024-25 Godrej Agrovet Limited (GAVL) continued to create value for its stakeholders by focusing on margin expansion initiatives across all its businesses. As a result of this, I am delighted to share that FY 2024-25 was the best year of profitability for Standalone Godrej Agrovet Limited. On a consolidated basis as well, profitability improved across all businesses except Astec LifeSciences and Poultry & Processed Foods and Profit before tax (excluding non-recurring & exceptional items) grew by 12%. This growth in profitability was primarily driven by exceptional performance of the domestic Crop Protection business, Vegetable Oil business and margin expansion in Animal Feed business.

“The domestic Crop Protection business delivered stellar performance primarily driven by higher volumes of in-house products. The performance of the Vegetable Oil business improved significantly on the back of improved end-product prices. Animal Feed business recorded a significant increase in segment margins led by favorable commodity positions and cost optimization. Our Dairy business continued to build on the remarkable turnaround and profitability improved year-on-year due to focused efforts on improving operational efficiencies and improved milk spread.

“The Poultry business recorded a decline in topline and profitability. Decline in topline was on account of lower volumes in live bird category in line with our strategy to improve the salience of branded categories. While volumes in the branded category improved, elevated input costs & unfavorable product & channel mix adversely impacted profitability. For Astec Lifesciences, FY25 proved to be another challenging year as it was severely impacted by continued demand-supply imbalance, volume headwinds and price corrections in both enterprise and contract manufacturing portfolios.

“During the year, Godrej Agrovet continued to focus on achieving the long-term sustainability targets guided by the Godrej Group's Good & Green vision. For second year in a row, we have been included in “A” list – leadership band of Climate Disclosure Project’s (CDP) climate disclosures & also for Water & Forests (Palm Oil) disclosure. GAVL’s CDP scores are ahead of the global averages. We achieved good progress in achieving 2025 sustainability targets led by (a) 81% of energy consumption from clean renewable energy sources as against target of 90% and (b) being a water positive company already conserving 16 times more water than the consumption. The Company has also been conferred with CII’s coveted & prestigious Climate Action Programme ‘CAP 2.0 Award’ in “Oriented” category.